Fleury S.A. (FLRY3) - Total Liabilities
Based on the latest financial reports, Fleury S.A. (FLRY3) has total liabilities worth R$8.05 Billion BRL (≈ $1.58 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore FLRY3 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Fleury S.A. - Total Liabilities Trend (2006–2025)
This chart illustrates how Fleury S.A.'s total liabilities have evolved over time, based on quarterly financial data. See Fleury S.A. (FLRY3) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Fleury S.A. Competitors by Total Liabilities
The table below lists competitors of Fleury S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kansai Nerolac Paints Limited
NSE:KANSAINER
|
India | Rs18.86 Billion |
|
Beijing Fuxing Xiaocheng Electronic Technology Co Ltd
SHE:300139
|
China | CN¥257.53 Million |
|
Aerospace Industrial Development Corp
TW:2634
|
Taiwan | NT$33.34 Billion |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
USA | $14.80 Billion |
|
OFG Bancorp
NYSE:OFG
|
USA | $11.08 Billion |
|
Shanghai Weaver Network Co Ltd
SHG:603039
|
China | CN¥1.62 Billion |
|
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285
|
China | CN¥2.28 Billion |
|
Shenzhen Forms Syntron Information Co Ltd
SHE:300468
|
China | CN¥132.65 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Fleury S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Fleury S.A. market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fleury S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fleury S.A. (2006–2025)
The table below shows the annual total liabilities of Fleury S.A. from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | R$8.12 Billion ≈ $1.59 Billion |
+5.68% |
| 2024-12-31 | R$7.69 Billion ≈ $1.51 Billion |
+18.84% |
| 2023-12-31 | R$6.47 Billion ≈ $1.27 Billion |
+27.07% |
| 2022-12-31 | R$5.09 Billion ≈ $998.88 Million |
+20.65% |
| 2021-12-31 | R$4.22 Billion ≈ $827.90 Million |
+12.10% |
| 2020-12-31 | R$3.76 Billion ≈ $738.56 Million |
+12.77% |
| 2019-12-31 | R$3.34 Billion ≈ $654.91 Million |
+54.49% |
| 2018-12-31 | R$2.16 Billion ≈ $423.93 Million |
+18.66% |
| 2017-12-31 | R$1.82 Billion ≈ $357.27 Million |
+23.86% |
| 2016-12-31 | R$1.47 Billion ≈ $288.46 Million |
-5.08% |
| 2015-12-31 | R$1.55 Billion ≈ $303.90 Million |
-5.38% |
| 2014-12-31 | R$1.64 Billion ≈ $321.17 Million |
+7.53% |
| 2013-12-31 | R$1.52 Billion ≈ $298.67 Million |
+47.46% |
| 2012-12-31 | R$1.03 Billion ≈ $202.55 Million |
-13.97% |
| 2011-12-31 | R$1.20 Billion ≈ $235.43 Million |
+279.26% |
| 2010-12-31 | R$316.37 Million ≈ $62.08 Million |
-24.16% |
| 2009-12-31 | R$417.16 Million ≈ $81.85 Million |
-10.27% |
| 2008-12-31 | R$464.92 Million ≈ $91.23 Million |
+14.91% |
| 2007-12-31 | R$404.60 Million ≈ $79.39 Million |
+83.74% |
| 2006-12-31 | R$220.20 Million ≈ $43.21 Million |
-- |
About Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more